{"DataElement":{"publicId":"2179892","version":"2","preferredName":"Adverse Event Cancer Treatment Related Type","preferredDefinition":"the description a of a treatment modality or patient disease to which a reported adverse event may be related.","longName":"AE_CA_TX_R/T_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2195340","version":"1","preferredName":"Adverse Event Cancer Treatment","preferredDefinition":"information related to the adverse event of cancer treatment.","longName":"AE_CA_TX","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2184272","version":"1","preferredName":"Adverse Event","preferredDefinition":"An unwanted effect caused by a drug or therapy.  Such effects can be drug related, dose related, route related, patient related, caused by an interaction with another drug, or caused by opioid initiation or dose escalation.","longName":"Adverse Event","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-194E-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":"Change concept code to C41331 as C2861 is retired per EVS. dw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3693397","version":"1","preferredName":"Neoplasm Therapeutic Procedure","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C3262:C49236","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D743B17B-E4D2-394C-E040-BB89AD4312FF","latestVersionIndicator":"Yes","beginDate":"2013-03-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2013-03-06","modifiedBy":"ONEDATA","dateModified":"2013-03-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED52B5CF-00E3-245D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"03/06/2013 - tc - Removed retired concept C15368 and replaced with NCIt concept C49236.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2179887","version":"2","preferredName":"Adverse Event Cancer Treatment Related Type","preferredDefinition":"the description a of a treatment modality or patient disease to which a reported adverse event may be related.","longName":"AE_CA_TX_R/T_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"22","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Chemotherapy","valueDescription":"Chemotherapy","ValueMeaning":{"publicId":"2558484","version":"1","preferredName":"Chemotherapy","longName":"2558484","preferredDefinition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term is used to describe any therapy involving the use of chemical-based agents, it is particularly used to refer to the use of chemical-based agents to treat cancer. Antineoplastic chemotherapy works by arresting or killing the growth and spread of cancer cells. Chemotherapy may also include agents that enhance immune function or alter hormonal activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B181-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2014-12-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C72B7D13-5A30-78C1-E040-BB89AD431933","beginDate":"2004-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-08-13","modifiedBy":"ONEDATA","dateModified":"2012-08-13","deletedIndicator":"No"},{"value":"Radiation therapy","valueDescription":"Radiation Therapy","ValueMeaning":{"publicId":"2559934","version":"1","preferredName":"Radiation Therapy","longName":"2559934","preferredDefinition":"use PHOTOTHERAPY, LASER THERAPY, or ULTRAVIOLET THERAPY for therapeutic radiation with visible, laser, or ultraviolet light, respectively.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation Therapy","conceptCode":"C15313","definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B72B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2009-09-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C72B7D13-5A3A-78C1-E040-BB89AD431933","beginDate":"2004-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-08-13","modifiedBy":"ONEDATA","dateModified":"2012-08-13","deletedIndicator":"No"},{"value":"Combined modality","valueDescription":"combined modality","ValueMeaning":{"publicId":"2567994","version":"1","preferredName":"combined modality","longName":"2567994","preferredDefinition":"combined modality","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D6A7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-07","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C72B7D13-5A44-78C1-E040-BB89AD431933","beginDate":"2004-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-08-13","modifiedBy":"ONEDATA","dateModified":"2012-08-13","deletedIndicator":"No"},{"value":"Disease","valueDescription":"disease","ValueMeaning":{"publicId":"2567995","version":"1","preferredName":"disease","longName":"2567995","preferredDefinition":"disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D6A8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-07","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C72B7D13-5A4E-78C1-E040-BB89AD431933","beginDate":"2004-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-08-13","modifiedBy":"ONEDATA","dateModified":"2012-08-13","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2567790","version":"1","preferredName":"Other","longName":"2567790","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D5DB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"KUMMEROA","dateModified":"2023-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C72B7D13-5A58-78C1-E040-BB89AD431933","beginDate":"2004-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-08-13","modifiedBy":"ONEDATA","dateModified":"2012-08-13","deletedIndicator":"No"},{"value":"Surgery","valueDescription":"Surgery","ValueMeaning":{"publicId":"2560125","version":"1","preferredName":"Surgery","longName":"2560125","preferredDefinition":"A specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surgery","conceptCode":"C17173","definition":"The branch of medical science that treats disease or injury by operative procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B7EA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2009-09-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C72B7D13-5A62-78C1-E040-BB89AD431933","beginDate":"2008-04-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-08-13","modifiedBy":"ONEDATA","dateModified":"2012-08-13","deletedIndicator":"No"},{"value":"Device","valueDescription":"Medical_Device","ValueMeaning":{"publicId":"2575507","version":"1","preferredName":"Medical_Device","longName":"2575507","preferredDefinition":"Medical device - any machinery designed to aid diagnostic and medical therapies. Medical device has to be designed with rigorous safety standards. There are several basic types of medical devices: life support equipment used to maintain a patient's body functions; therapeutic equipment; monitors and detectors to measure the indexes of a patient's state; imagine machines and laboratory equipment used with diagnostic and status monitoring purposes. In insurance parlance, the term is usually synonymous with assistive device, although it may include medical supplies.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medical Device","conceptCode":"C16830","definition":"Any physical object that is useful for prevention, diagnosis, monitoring, or treatment of disease or other conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F400-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-06","endDate":null,"createdBy":"HARDINGR","dateCreated":"2005-07-06","modifiedBy":"ONEDATA","dateModified":"2005-07-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C72B7D13-5A6C-78C1-E040-BB89AD431933","beginDate":"2008-04-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-08-13","modifiedBy":"ONEDATA","dateModified":"2012-08-13","deletedIndicator":"No"},{"value":"Concomitant medication","valueDescription":"Concomitant Agent","ValueMeaning":{"publicId":"2744968","version":"1","preferredName":"Concomitant Agent","longName":"2744968","preferredDefinition":"A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concomitant Agent","conceptCode":"C70902","definition":"A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol's complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4BB3A0D5-BF6D-3B82-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-04-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C72B7D13-5A76-78C1-E040-BB89AD431933","beginDate":"2008-04-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-08-13","modifiedBy":"ONEDATA","dateModified":"2012-08-13","deletedIndicator":"No"},{"value":"Investigational agent","valueDescription":"Investigational Agent","ValueMeaning":{"publicId":"3198846","version":"1","preferredName":"Investigational Agent","longName":"3198846","preferredDefinition":"In the process of being studied; experimental.  (NCI): An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Investigational","conceptCode":"C28041","definition":"In the process of being studied; experimental.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D999C94-A560-E80A-E040-BB89AD4330DB","latestVersionIndicator":"Yes","beginDate":"2011-03-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C72B7D13-5A80-78C1-E040-BB89AD431933","beginDate":"2011-03-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-08-13","modifiedBy":"ONEDATA","dateModified":"2012-08-13","deletedIndicator":"No"},{"value":"Endocrine Therapy","valueDescription":"Endocrine Therapy","ValueMeaning":{"publicId":"3021569","version":"1","preferredName":"Endocrine Therapy","longName":"3021569","preferredDefinition":"Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level. The treatment may include administration of hormones or hormone analogs to the patient, or decreasing the level of hormones in the body by using hormone antagonists, or hormone ablation therapy. The concept covers but not limited to: intermittent or permanent hormone suppression or ablation in treatment of hormone-dependent tumors, hormone replacement therapy of any kind, hormonal component of gender reassignment therapy, hormonal contraception, surgical and radiation castration.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hormone Therapy","conceptCode":"C15445","definition":"Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"818DED3A-497D-17D3-E040-BB89AD4304FC","latestVersionIndicator":"Yes","beginDate":"2010-03-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C72B7D13-5A8A-78C1-E040-BB89AD431933","beginDate":"2011-03-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-08-13","modifiedBy":"ONEDATA","dateModified":"2012-08-13","deletedIndicator":"No"},{"value":"Immunotherapy","valueDescription":"Immunotherapy","ValueMeaning":{"publicId":"2570354","version":"1","preferredName":"Immunotherapy","longName":"2570354","preferredDefinition":"(IM-yoo-no-THER-a-pee) Treatment to stimulate or restore the ability of the immune system to fight infections and other diseases. Also used to lessen side effects that may be caused by some cancer treatments.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunotherapy","conceptCode":"C15262","definition":"Therapy designed to induce changes in a patient's immune status in order to treat disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DFDF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C72B7D13-5A94-78C1-E040-BB89AD431933","beginDate":"2011-03-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-08-13","modifiedBy":"ONEDATA","dateModified":"2012-08-13","deletedIndicator":"No"},{"value":"Biological Therapy","valueDescription":"Biological Therapy","ValueMeaning":{"publicId":"3198847","version":"1","preferredName":"Biological Therapy","longName":"3198847","preferredDefinition":"Biological therapy is a form of treatment that implies the administration of substances which produce a biological reaction in the organism enhancing or restoring the host immune response, modifying the behavior of cancer cells, blocking the pathways of cell neoplastic transformation and tumor ability to metastasize, or facilitating the repairment of cells damaged by aggressive forms of cancer treatment.  It includes the use of sera, antitoxins, vaccines, genes, cells, tissues, and organs","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biological Therapy","conceptCode":"C15187","definition":"A type of treatment that uses substances derived from or made by living organisms to treat disease; this includes both naturally occurring and synthetic products.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D999C94-A599-E80A-E040-BB89AD4330DB","latestVersionIndicator":"Yes","beginDate":"2011-03-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C72B7D13-5A9E-78C1-E040-BB89AD431933","beginDate":"2011-03-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-08-13","modifiedBy":"ONEDATA","dateModified":"2012-08-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2207973","version":"1","preferredName":"Related Type","preferredDefinition":"Related; connected or associated.:Type; a subdivision of a particular kind of thing.","longName":"C25648:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Relationship","conceptCode":"C25648","definition":"A state of connectedness between people, objects, or events; to be associated or connected with something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3728-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C72B7D13-5A1A-78C1-E040-BB89AD431933","latestVersionIndicator":"Yes","beginDate":"2004-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-08-13","modifiedBy":"COOPERM","dateModified":"2014-12-09","changeDescription":"Updated Max Length from 20.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811912","version":"1","longName":"Head and Neck","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811951","version":"1","longName":"Adverse Events","context":"CTEP"}]},{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"2859992","version":"1","longName":"Adverse Events CRF","context":"NCIP"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000681","version":"1","longName":"Adverse Events","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"AE_CA_TX_R/T_TP","type":"USED_BY","context":"CITN"},{"name":"Theradex","type":"USED_BY","context":"Theradex"}],"ReferenceDocuments":[{"name":"To what is the adverse event","type":"Alternate Question Text","description":"To what is the adverse event attributed","url":null,"context":"CTEP"},{"name":"caBIG Adverse Events Document Text","type":"Alternate Question Text","description":"What is most likely cause of the AE?","url":null,"context":"NCIP"},{"name":"Optional NCI Standard CRF Question","type":"COMMENT","description":"No requirement for inclusion on CRF; use this data element if needed.","url":null,"context":"NCIP"},{"name":"To what is the AE attributed?","type":"Preferred Question Text","description":"To what is the AE attributed?","url":null,"context":"CTEP"},{"name":"COG CRF TEXT 1","type":"Alternate Question Text","description":"Adverse Event related to:","url":null,"context":"CTEP"},{"name":"CITN","type":"Alternate Question Text","description":"If not related to Investigational Agent, to what is the AE attributed?","url":null,"context":"CITN"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Related to","url":null,"context":"Theradex"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C72B7D13-5AB2-78C1-E040-BB89AD431933","latestVersionIndicator":"Yes","beginDate":"2004-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-08-13","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Updated VD to new Max Length","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}